Citations

Clear

5212 citation(s) found for "Wang, Li-Ju".

Extracorporeal membrane oxygenation using a modified cardiopulmonary bypass system
Song, Xuan , Wang, Chunting , Wang, Hao , Kashani, Kianoush

Mayo Clinic

Journal of Translational Internal Medicine | June 15, 2022 | Volume: 10 | Issue: 2 | Pages: 175-177

10.2478/jtim-2022-0015 | PMID 35959450 Get It

Long-term safety and maintenance of efficacy of sodium oxybate in the treatment of narcolepsy with cataplexy in pediatric patients
Lecendreux, Michel , Rosen, Carol L. , Ruoff, Chad , Black, Jed , Parvataneni, Rupa, Guinta, Diane, Wang, Y. Grace, Ruoff, Chad M , Plazzi, Giuseppe , Dauvilliers, Yves , Mignot, Emmanuel

Mayo Clinic

Journal of Clinical Sleep Medicine | June 13, 2022 | Volume: 18 | Issue: 9 | Pages: 2217-2227

10.5664/jcsm.10090 | PMID 35689598 Get It

A Systematic Review Supporting the Endocrine Society Clinical Practice Guideline for the Management of Hyperglycemia in Adults Hospitalized for Noncritical Illness or Undergoing Elective Surgical Procedures
Seisa, Mohamed O. , Saadi, Samer , Nayfeh, Tarek , Muthusamy, Kalpana , Shah, Sahrish, Jawaid, Tabinda , Abd‐Rabu, Rami , Antinori-Lent, Kellie, Donihi, Amy C. , Drincic, Andjela, Luger, Anton, Roldan, Victor D. Torres , Urtecho, Meritxell , Shah, Sahrish H, Hasan, Bashar , Abd-Rabu, Rami, Muniyappa, Ranganath , Torres Roldan, Victor D , Nayfeh, Tarek , Saadi, Samer , Firwana, Mohammed , Hasan, Bashar , Korytkowski, Mary T. , Muniyappa, Ranganath , Wang, Zhen , Murad, M. Hassan

Mayo Clinic

The Journal of Clinical Endocrinology & Metabolism | June 12, 2022 | Volume: 107 | Issue: 8 | Pages: 2139-2147

10.1210/clinem/dgac277 | PMID 35690929 Get It

AbstractContextIndividuals with diabetes or newly recognized hyperglycemia account for over 30% of noncritically ill hospitalized patients. Management of hyperglycemia in these patients is challenging.ObjectiveTo support development of the Endocrine Society Clinical Practice Guideline for management of hyperglycemia in adults hospitalized for noncritical illness or undergoing elective surgical procedures.MethodsWe searched several databases for studies addressing 10 questions provided by a guideline panel from the Endocrine Society. Meta-analysis was conducted when feasible. The Grading of Recommendations Assessment, Development and Evaluation (GRADE) methodology was used to assess certainty of evidence.ResultsWe included 94 studies reporting on 135 553 patients. Compared with capillary blood glucose, continuous glucose monitoring increased the number of patients identified with hypoglycemia and decreased mean daily blood glucose (BG) (very low certainty). Data on continuation of insulin pump therapy in hospitalized adults were sparse. In hospitalized patients receiving glucocorticoids, combination neutral protamine hagedorn (NPH) and basal-bolus insulin was associated with lower mean BG compared to basal-bolus insulin alone (very low certainty). Data on NPH insulin vs basal-bolus insulin in hospitalized adults receiving enteral nutrition were inconclusive. Inpatient diabetes education was associated with lower HbA1c at 3 and 6 months after discharge (moderate certainty) and reduced hospital readmissions (very low certainty). Preoperative HbA1c level < 7% was associated with shorter length of stay, lower postoperative BG and a lower number of neurological complications and infections, but a higher number of reoperations (very low certainty). Treatment with glucagon-like peptide-1 agonists or dipeptidyl peptidase-4 inhibitors in hospitalized patients with type 2 diabetes and mild hyperglycemia was associated with lower frequency of hypoglycemic events than insulin therapy (low certainty). Caloric oral fluids before surgery in adults with diabetes undergoing surgical procedures did not affect outcomes (very low certainty). Counting carbohydrates for prandial insulin dosing did not affect outcomes (very low certainty). Compared with scheduled insulin (basal-bolus or basal insulin + correctional insulin), correctional insulin was associated with higher mean daily BG and fewer hypoglycemic events (low certainty).ConclusionThe certainty of evidence supporting many hyperglycemia management decisions is low, emphasizing importance of shared decision-making and consideration of other decisional factors.
Glycogen Synthase Kinase-3 Inhibition Sensitizes Pancreatic Cancer Cells to Chemotherapy by Abrogating the TopBP1/ATR-Mediated DNA Damage Response
Madamsetty, Vijay Sagar , Kiers, Spencer, Alekhina, Olga, Ugolkov, Andrey , Dubé, John J. , Zhang, Yu, Zhang, Jin‐San , Wang, Enfeng , Dutta, Shamit K., Schmitt, Daniel M. , Kozikowski, Alan P. , Mazar, Andrew P. , Billadeau, Daniel D. , Alekhina, Olga , Dube, John, Zhang, Jin-San , Schmitt, Daniel M , Giles, Francis Joseph , Billadeau, Daniel D , Madamsetty, Vijay S , Ding, Li , Dube, John, Mukhopadhyay, Debabrata

Mayo Clinic

Clinical Cancer Research | June 11, 2022 | Volume: 25 | Issue: 21 | Pages: 6452-6462

10.1158/1078-0432.ccr-19-0799 | PMID 31533931 Get It

Abstract Purpose: Pancreatic ductal adenocarcinoma (PDAC) is a predominantly fatal common malignancy with inadequate treatment options. Glycogen synthase kinase 3β (GSK-3β) is an emerging target in human malignancies including PDAC. Experimental Design: Pancreatic cancer cell lines and patient-derived xenografts were treated with a novel GSK-3 inhibitor 9-ING-41 alone or in combination with chemotherapy. Activation of the DNA damage response pathway and S-phase arrest induced by gemcitabine were assessed in pancreatic tumor cells with pharmacologic inhibition or siRNA depletion of GSK-3 kinases by immunoblotting, flow cytometry, and immunofluorescence. Results: 9-ING-41 treatment significantly increased pancreatic tumor cell killing when combined with chemotherapy. Inhibition of GSK-3 by 9-ING-41 prevented gemcitabine-induced S-phase arrest suggesting an impact on the ATR-mediated DNA damage response. Both 9-ING-41 and siRNA depletion of GSK-3 kinases impaired the activation of ATR leading to the phosphorylation and activation of Chk1. Mechanistically, depletion or knockdown of GSK-3 kinases resulted in the degradation of the ATR-interacting protein TopBP1, thus limiting the activation of ATR in response to single-strand DNA damage. Conclusions: These data identify a previously unknown role for GSK-3 kinases in the regulation of the TopBP1/ATR/Chk1 DNA damage response pathway. The data also support the inclusion of patients with PDAC in clinical studies of 9-ING-41 alone and in combination with gemcitabine.
ATR-mediated CD47 and PD-L1 up-regulation restricts radiotherapy-induced immune priming and abscopal responses in colorectal cancer
Hsieh, Cheng‐En , Krishnan, Sunil , Wu, Ren‐Chin , Boda, Akash R. , Liu, Arthur , Winkler, Michelle , Hsu, Wen‐Hao , Lin, Steven H. , Hung, Mien‐Chie , Bhanu, Krithikaa Rajkumar , Srinivasamani, Anupallavi, Azevedo, Ricardo , Chou, Yung‐Chih , DePinho, Ronald A. , Gubin, Matthew M. , Slay, Ravaen, Hegde, Shweta , Hartley, Genevieve , Lea, Spencer T. , Prasad, Rishika , Morrow, Brittany, Couillault, Coline , Steiner, Madeline , Wang, Chun‐Chieh, Venkatesulu, Bhanu Prasad , Curran, Michael A. , Hsieh, Rodney Cheng-En , Lin, Steven H , Chan, Li-Chuan , De Azevedo, Ricardo Alexandre , Chou, Yung-Chih , DePinho, Ronald A , Gubin, Matthew , Vilar, Eduardo , Chen, Chao Hsien , Jayaprakash, Priyamvada , Lea, Spencer T , Prasad, Rishika , Couillault, Coline Agnes , Wang, Chun-Chieh , Taniguchi, Cullen , Kim, Betty Y S , Chen, Junjie , Rudqvist, Nils-Petter , Curran, Michael A , Krishnan, Sunil , Liu, Arthur J , Kim, Betty Y.S. , Chen, Junjie

Mayo Clinic

Science Immunology | June 10, 2022 | Volume: 7 | Issue: 72 | Pages: No page available

10.1126/sciimmunol.abl9330 | PMID 35687697 Get It

Radiotherapy (RT) of colorectal cancer (CRC) can prime adaptive immunity against tumor-associated antigen (TAA)–expressing CRC cells systemically. However, abscopal tumor remissions are extremely rare, and the postirradiation immune escape mechanisms in CRC remain elusive. Here, we found that irradiated CRC cells used ATR-mediated DNA repair signaling pathway to up-regulate both CD47 and PD-L1, which through engagement of SIRPα and PD-1, respectively, prevented phagocytosis by antigen-presenting cells and thereby limited TAA cross-presentation and innate immune activation. This postirradiation CD47 and PD-L1 up-regulation was observed across various human solid tumor cells. Concordantly, rectal cancer patients with poor responses to neoadjuvant RT exhibited significantly elevated postirradiation CD47 levels. The combination of RT, anti-SIRPα, and anti–PD-1 reversed adaptive immune resistance and drove efficient TAA cross-presentation, resulting in robust TAA-specific CD8 T cell priming, functional activation of T effectors, and increased T cell clonality and clonal diversity. We observed significantly higher complete response rates to RT/anti-SIRPα/anti–PD-1 in both irradiated and abscopal tumors and prolonged survival in three distinct murine CRC models, including a cecal orthotopic model. The efficacy of triple combination therapy was STING dependent as knockout animals lost most benefit of adding anti-SIRPα and anti–PD-1 to RT. Despite activation across the myeloid stroma, the enhanced dendritic cell function accounts for most improvements in CD8 T cell priming. These data suggest ATR-mediated CD47 and PD-L1 up-regulation as a key mechanism restraining radiation-induced immune priming. RT combined with SIRPα and PD-1 blockade promotes robust antitumor immune priming, leading to systemic tumor regressions.
Delirium prediction in the ICU: designing a screening tool for preventive interventions
Sheikhalishahi, Seyedmostafa , Torbic, Heather , Yeung, Wesley , Wang, Tiffany , Birst, Jennifer, Osmani, Venet , Bhattacharyya, Anirban , Osmani, Venet , Duggal, Abhijit , Celi, Leo Anthony

Mayo Clinic

JAMIA Open | June 10, 2022 | Volume: 5 | Issue: 2 | Pages: No page available

10.1093/jamiaopen/ooac048 | PMID 35702626 Get It

Abstract Introduction Delirium occurrence is common and preventive strategies are resource intensive. Screening tools can prioritize patients at risk. Using machine learning, we can capture time and treatment effects that pose a challenge to delirium prediction. We aim to develop a delirium prediction model that can be used as a screening tool. Methods From the eICU Collaborative Research Database (eICU-CRD) and the Medical Information Mart for Intensive Care version III (MIMIC-III) database, patients with one or more Confusion Assessment Method-Intensive Care Unit (CAM-ICU) values and intensive care unit (ICU) length of stay greater than 24 h were included in our study. We validated our model using 21 quantitative clinical parameters and assessed performance across a range of observation and prediction windows, using different thresholds and applied interpretation techniques. We evaluate our models based on stratified repeated cross-validation using 3 algorithms, namely Logistic Regression, Random Forest, and Bidirectional Long Short-Term Memory (BiLSTM). BiLSTM represents an evolution from recurrent neural network-based Long Short-Term Memory, and with a backward input, preserves information from both past and future. Model performance is measured using Area Under Receiver Operating Characteristic, Area Under Precision Recall Curve, Recall, Precision (Positive Predictive Value), and Negative Predictive Value metrics. Results We evaluated our results on 16 546 patients (47% female) and 6294 patients (44% female) from eICU-CRD and MIMIC-III databases, respectively. Performance was best in BiLSTM models where, precision and recall changed from 37.52% (95% confidence interval [CI], 36.00%–39.05%) to 17.45 (95% CI, 15.83%–19.08%) and 86.1% (95% CI, 82.49%–89.71%) to 75.58% (95% CI, 68.33%–82.83%), respectively as prediction window increased from 12 to 96 h. After optimizing for higher recall, precision and recall changed from 26.96% (95% CI, 24.99%–28.94%) to 11.34% (95% CI, 10.71%–11.98%) and 93.73% (95% CI, 93.1%–94.37%) to 92.57% (95% CI, 88.19%–96.95%), respectively. Comparable results were obtained in the MIMIC-III cohort. Conclusions Our model performed comparably to contemporary models using fewer variables. Using techniques like sliding windows, modification of threshold to augment recall and feature ranking for interpretability, we addressed shortcomings of current models.
Postoperative protocols following endoscopic skull base surgery: An evidence‐based review with recommendations
Abiri, Arash , Patel, Tirth , Nguyen, Emily , Tajudeen, Bobby A. , Schlosser, Rodney J. , Adappa, Nithin D. , Adappa, Nithin D. , Choby, Garret , Wang, Eric W , Kuan, Edward C , Schlosser, Rodney J , Birkenbeuel, Jack L. , Choby, Garret , Adappa, Nithin D.

Mayo Clinic

International Forum of Allergy & Rhinology | June 9, 2022 | Volume: 13 | Issue: 1 | Pages: 42-71

10.1002/alr.23041 | PMID 35678720 Get It

AbstractBackgroundPostoperative management strategies for endoscopic skull base surgery (ESBS) vary widely because of limited evidence‐based guidance.MethodsThe PubMed, EMBASE, and Cochrane databases were systematically reviewed from January 1990 through February 2022 to examine 18 postoperative considerations for ESBS. Nonhuman studies, articles written in a language other than English, and case reports were excluded. Studies were assessed for levels of evidence, and each topic's aggregate grade of evidence was evaluated.ResultsA total of 74 studies reporting on 18 postoperative practices were reviewed. Postoperative pain management, prophylactic antibiotics, and lumbar drain use had the highest grades of evidence (B). The literature currently lacks high quality evidence for a majority of the reviewed ESBS precautions. There were no relevant studies to address postoperative urinary catheter use and medical intracranial pressure reduction.ConclusionThe evidence for postoperative ESBS precautions is heterogeneous, scarce, and generally of low quality. Although this review identified the best evidence available in the literature, it suggests the urgent need for more robust evidence. Therefore, additional high‐quality studies are needed in order to devise optimal postoperative ESBS protocols.
Migraine with aura associates with a higher artificial intelligence: ECG atrial fibrillation prediction model output compared to migraine without aura in both women and men
Chiang, Chia‐Chun , Chhabra, Nikita , Chao, Chieh‐Ju , Wang, Han , Zhang, Nan , Lim, Elisabeth S. , Baez‐Suarez, Abraham, Attia, Zachi I. , Schwedt, Todd J. , Dodick, David W. , Cutrer, F. Michael , Friedman, Paul A. , Lim, Elisabeth, Cutrer, Fred Michael , Noseworthy, Peter A , Dodick, David W , Chiang, Chia-Chun , Schwedt, Todd J , Attia, Zachi I , Chao, Chieh-Ju , Wang, Han , Noseworthy, Peter A.

Mayo Clinic

Headache: The Journal of Head and Face Pain | June 9, 2022 | Volume: 62 | Issue: 8 | Pages: 939-951

10.1111/head.14339 | PMID 35676887 Get It

Abstract Objective To compare the artificial intelligence‐enabled electrocardiogram (AI‐ECG) atrial fibrillation (AF) prediction model output in patients with migraine with aura (MwA) and migraine without aura (MwoA). Background MwA is associated with an approximately twofold risk of ischemic stroke. Longitudinal cohort studies showed that patients with MwA have a higher incidence of developing AF compared to those with MwoA. The Mayo Clinic Cardiology team developed an AI‐ECG algorithm that calculates the probability of concurrent paroxysmal or impending AF in ECGs with normal sinus rhythm (NSR). Methods Adult patients with an MwA or MwoA diagnosis and at least one NSR ECG within the past 20 years at Mayo Clinic were identified. Patients with an ECG‐confirmed diagnosis of AF were excluded. For each patient, the ECG with the highest AF prediction model output was used as the index ECG. Comparisons between MwA and MwoA were conducted in the overall group (including men and women of all ages), women only, and men only in each age range (18 to <35, 35 to <55, 55 to <75, ≥75 years), and adjusted for age, sex, and six common vascular comorbidities that increase risk for AF. Results The final analysis of our cross‐sectional study included 40,002 patients (17,840 with MwA, 22,162 with MwoA). The mean (SD) age at the index ECG was 48.2 (16.0) years for MwA and 45.9 (15.0) years for MwoA ( p < 0.001). The AF prediction model output was significantly higher in the MwA group compared to MwoA (mean [SD] 7.3% [15.0%] vs. 5.6% [12.4%], mean difference [95% CI] 1.7% [1.5%, 2.0%], p < 0.001). After adjusting for vascular comorbidities, the difference between MwA and MwoA remained significant in the overall group (least square means of difference [95% CI] 0.7% [0.4%, 0.9%], p < 0.001), 18 to <35 (0.4% [0.1%, 0.7%], p = 0.022), and 35 to <55 (0.5% [0.2%, 0.8%], p < 0.001), women of all ages (0.6% [0.3%, 0.8%], p < 0.001), men of all ages (1.0% [0.4%, 1.6%], p = 0.002), women 35 to <55 (0.6% [0.3%, 0.9%], p < 0.001), and men 18 to <35 (1.2% [0.3%, 2.1%], p = 0.008). Conclusions Utilizing a novel AI‐ECG algorithm on a large group of patients, we demonstrated that patients with MwA have a significantly higher AF prediction model output, implying a higher probability of concurrent paroxysmal or impending AF, compared to MwoA in both women and men. Our results suggest that MwA is an independent risk factor for AF, especially in patients <55 years old, and that AF‐mediated cardioembolism may play a role in the migraine–stroke association for some patients.
Primary cilia in satellite cells are the mechanical sensors for muscle hypertrophy
Li, Weijun , He, Kai , Ma, Xiaoyu , Pignolo, Robert J. , Sieck, Gary C. , Hu, Jinghua , Wang, Haitao , Zhu, Zhenhong , He, Kai , Ma, Xiaoyu , Pignolo, Robert J , Sieck, Gary , Wang, Haitao

Mayo Clinic

Proceedings of the National Academy of Sciences | June 7, 2022 | Volume: 119 | Issue: 24 | Pages: No page available

10.1073/pnas.2103615119 | PMID 35671424 Get It

Skeletal muscle atrophy is commonly associated with aging, immobilization, muscle unloading, and congenital myopathies. Generation of mature muscle cells from skeletal muscle satellite cells (SCs) is pivotal in repairing muscle tissue. Exercise therapy promotes muscle hypertrophy and strength. Primary cilium is implicated as the mechanical sensor in some mammalian cells, but its role in skeletal muscle cells remains vague. To determine mechanical sensors for exercise-induced muscle hypertrophy, we established three SC-specific cilium dysfunctional mouse models— Myogenic factor 5 ( Myf5 ) -Arf-like Protein 3 ( Arl3 ) −/− , Paired box protein Pax-7 ( Pax7 )- Intraflagellar transport protein 88 homolog ( Ift88 ) −/− , and Pax7-Arl3 −/− —by specifically deleting a ciliary protein ARL3 in MYF5-expressing SCs, or IFT88 in PAX7-expressing SCs, or ARL3 in PAX7-expressing SCs, respectively. We show that the Myf5-Arl3 −/− mice develop grossly the same as WT mice. Intriguingly, mechanical stimulation-induced muscle hypertrophy or myoblast differentiation is abrogated in Myf5-Arl3 −/− and Pax7-Arl3 −/− mice or primary isolated Myf5-Arl3 −/− and Pax7-Ift88 −/− myoblasts, likely due to defective cilia-mediated Hedgehog (Hh) signaling. Collectively, we demonstrate SC cilia serve as mechanical sensors and promote exercise-induced muscle hypertrophy via Hh signaling pathway.
Prediction of Incident Dementia Using Patient Temporal Health Status
Ibrahim, Omar A. , Wang, Yanshan , Vassilaki, Maria , Petersen, Ronald C. , Sohn, Sunghwan , St Sauver, Jennifer, Wang, Yanshan , Fu, Sunyang , Mielke, Michelle M. , Sauver, Jennifer L. St.

Mayo Clinic

Studies in Health Technology and Informatics | June 7, 2022 | Volume: No volume available | Issue: No issue available | Pages: No page available

10.3233/shti220180 | PMID 35673119 Get It

Dementia is one of the most prevalent health problems in the aging population. Despite the significant number of people affected, dementia diagnoses are often significantly delayed, missing opportunities to maximize life quality. Early identification of older adults at high risk for dementia may help to maximize current quality of life and to improve planning for future health needs in dementia patients. However, most existing risk prediction models predominantly use static variables, not considering temporal patterns of health status. This study used an attention-based time-aware model to predict incident dementia that incorporated longitudinal temporal health conditions. The predictive performance of the time-aware model was compared with three traditional models using static variables and demonstrated higher predictive power.